These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 8546123

  • 21. Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation.
    Kronenberg F, Trenkwalder E, Lingenhel A, Friedrich G, Lhotta K, Schober M, Moes N, König P, Utermann G, Dieplinger H.
    J Lipid Res; 1997 Sep; 38(9):1755-63. PubMed ID: 9323585
    [Abstract] [Full Text] [Related]

  • 22. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.
    Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W.
    Arterioscler Thromb; 1993 Nov; 13(11):1558-66. PubMed ID: 8218095
    [Abstract] [Full Text] [Related]

  • 23. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC, Coresh J, Marcovina SM, Powe NR, Levey AS, Giaculli F, Fink NE, Klag MJ.
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [Abstract] [Full Text] [Related]

  • 24. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC, Klag MJ, Marcovina SM, Liu YM, Jaar BG, Powe NR, Fink NE, Levey AS, Coresh J.
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [Abstract] [Full Text] [Related]

  • 25. High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay.
    Mooser V, Marcovina SM, Wang J, Hobbs HH.
    Clin Genet; 1997 Nov; 52(5):387-92. PubMed ID: 9520131
    [Abstract] [Full Text] [Related]

  • 26. Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patients.
    Emanuele E, Lusignani LS, Peros E, Montagna G, D'Angelo A, Montagna L, Geroldi D.
    Am J Nephrol; 2004 Nov; 24(2):221-9. PubMed ID: 15017119
    [Abstract] [Full Text] [Related]

  • 27. The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.
    Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, Thiery J, Koch M, von Eckardstein A, Dieplinger H.
    Kidney Int; 2004 Feb; 65(2):606-12. PubMed ID: 14717931
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 32. Urinary apolipoprotein (a) excretion in patients with proteinuria.
    Kostner KM, Banyai S, Banyai M, Bodlaj G, Maurer G, Derfler K, Hörl WH, Oberbauer R.
    Ann Med; 1998 Oct; 30(5):497-502. PubMed ID: 9814837
    [Abstract] [Full Text] [Related]

  • 33. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ, Elisaf MS, Karabina SA, Bairaktari E, Tselepis AD, Siamopoulos KC.
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [Abstract] [Full Text] [Related]

  • 34. The role of lipoprotein (a) in chronic kidney disease.
    Hopewell JC, Haynes R, Baigent C.
    J Lipid Res; 2018 Apr; 59(4):577-585. PubMed ID: 29378781
    [Abstract] [Full Text] [Related]

  • 35. The mysteries of lipoprotein(a).
    Utermann G.
    Science; 1989 Nov 17; 246(4932):904-10. PubMed ID: 2530631
    [Abstract] [Full Text] [Related]

  • 36. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients.
    Frischmann ME, Kronenberg F, Trenkwalder E, Schaefer JR, Schweer H, Dieplinger B, Koenig P, Ikewaki K, Dieplinger H.
    Kidney Int; 2007 May 17; 71(10):1036-43. PubMed ID: 17299521
    [Abstract] [Full Text] [Related]

  • 37. Is apolipoprotein(a) a susceptibility gene for type I diabetes mellitus and related to long-term survival?
    Kronenberg F, Auinger M, Trenkwalder E, Irsigler K, Utermann G, Dieplinger H.
    Diabetologia; 1999 Aug 17; 42(8):1021-7. PubMed ID: 10491765
    [Abstract] [Full Text] [Related]

  • 38. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.
    Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, Egger G, Utermann G, Willeit J.
    Circulation; 1999 Sep 14; 100(11):1154-60. PubMed ID: 10484534
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications.
    Levine DM, Gordon BR.
    Am J Kidney Dis; 1995 Jul 14; 26(1):162-9. PubMed ID: 7611248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.